10/6/26 16:18 | 10/5/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S.d | -1,037 | 187.29 | 0 | -6 | -11 | 46 | D | | | | | | | | | | | | | | |
10/6/26 16:18 | 10/5/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | M.d | 651 | 154.96 | 0 | 4 | 10 | 46 | D | | | | | | | | | | | | | | |
9/25/26 16:09 | 9/24/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | M.d | 2,008 | 155.11 | 0 | 13 | 37 | 48 | D | | | | | | | | | | | | | | |
9/25/26 16:09 | 9/24/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S.d | -2,460 | 190.00 | 0 | -13 | -21 | 48 | D | | | | | | | | | | | | | | |
9/22/26 16:07 | 9/21/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | M.d | 769 | 141.79 | 0 | 5 | 13 | 48 | D | | | | | | | | | | | | | | |
9/22/26 16:07 | 9/21/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S.d | -977 | 180.00 | 0 | -5 | -10 | 48 | D | | | | | | | | | | | | | | |
9/8/26 16:13 | 9/4/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S | -504 | 165.90 | 0 | -3 | -6 | 48 | D | | | | | | | | | | | | | | |
8/21/26 16:06 | 8/20/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | M.d | 769 | 141.79 | 0 | 5 | 11 | 54 | D | | | | | | | | | | | | | | |
8/21/26 16:06 | 8/20/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S.d | -977 | 180.00 | 0 | -5 | -9 | 54 | D | | | | | | | | | | | | | | |
4/22/26 13:26 | 4/21/26 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S | -536 | 140.00 | 0 | -4 | -7 | 54 | D | | | | | | | | | | | | | | |
11/26/25 16:30 | 11/25/25 | RGEN | Repligen Corp | DE | Health | BioPrd | Biological Products, (No Diag | Loeillot Olivier | MA | DO | CEO | S | -1,197 | 170.00 | 0 | -7 | -16 | 36 | D | | | | | | | | | | | | | | |